Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
Clinical trial NCT00660920 · COMPLETED
Trial details
- NCT number
- NCT00660920
- Sponsor
- Ariad Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2016-05-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.